SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

RedHill Biopharma Ltd. (RDHL)

RDHL RSS Feed
Add RDHL Price Alert      Hide Sticky   Hide Intro
Moderator: BioSpecialist, noretreat
Search This Board: 
Last Post: 2/28/2017 1:04:34 AM - Followers: 55 - Board type: Free - Posts Today: 1





Market cap :$170 Million
Cash: $80 Million
Price :$10


Shares Out: 17.1 M



 
Upcoming Milestones 1H 2017 :

RIZAPORT®(RHB-103):
•Re-submission of U.S. NDA

RHB-104:
•Second DSMB meeting for the MAP US Phase III study for Crohn’s disease, including safety and interim efficacy analysis, with evaluation of option of early stop for success for overwhelming efficacy -Q2/2017 <<<<<<<< POTENTIAL BLOCKBUSTER ..GLOBAL MARKET SIZE : $5+ BILLION

BEKINDA®(RHB-102):
•Top-line Phase III results (gastroenteritis) -mid-2017 <<<< MARKET SIZE $650+ MILLION
•Top-line Phase II results (IBS-D) -mid-2017

RHB-105 (H. pylori):
First Phase III study successfully met its primary endpoint with high statistical significance (p<0.001), confirmatory Phase III planned to be initiated H1/2017 <<<< POTENTIAL BLOCKBUSTER ..GLOBAL MARKET SIZE : $4+ Billion

 
 


 
RedHill Expects An Eventful Next Few Months
http://www.talkmarkets.com/content/stocks--equities/redhill-expects-an-eventful-next-few-months?post=112761

That being said, I believe RedHill BioPharma is worth approximately $500 million in value today. I see the most valuable asset as RHB-104 for Crohn's disease, followed by RHB-105 for H. pylori infection. Other important assets include Bekinda for gastroenteritis and IBS-D, RHB-104 for MS, and Yeliva and Mesupron in mid-stage development for various oncology indications. The company held $40.5 million in cash as of September 30, 2016, of which I'm including only $25 million into my sum-of-parts analysis. The company has no debt.


 








  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RDHL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
RDHL News: Report of Foreign Issuer (6-k) 02/23/2017 10:08:51 AM
RDHL News: RedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its Website 02/23/2017 10:07:12 AM
RDHL News: Annual and Transition Report (foreign Private Issuer) (20-f) 02/23/2017 09:45:01 AM
RDHL News: Report of Foreign Issuer (6-k) 02/23/2017 08:11:30 AM
RDHL News: RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Financial Results 02/23/2017 07:13:54 AM
PostSubject
#393  Sticky Note Every time I read about the pipeline listed noretreat 10/31/16 09:55:14 AM
#600   Respected analyst like this stock, in fact they DorseyE 02/28/17 01:04:33 AM
#599   Amen to that. Hopefully both Bekinda and RHB-104 toddski 02/25/17 08:44:13 PM
#598   RedHill Biopharma's (RDHL) CEO Dror Ben-Asher on Q4 Amatuer17 02/25/17 07:37:28 PM
#597   The market cap is $158 million with $66 Amatuer17 02/23/17 09:03:47 PM
#596   Yep. Bought some noretreat 02/23/17 03:41:34 PM
#595   So much cash and 9.00 has been breached. scottsmith 02/23/17 03:20:14 PM
#594   $66 million on hand right now noretreat 02/23/17 01:11:50 PM
#593   RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Amatuer17 02/23/17 08:00:22 AM
#592   You are correct on the near term events. RKInvHub 02/23/17 02:27:36 AM
#591   Check this out DorseyE 02/22/17 05:33:22 PM
#590   RedHill Biopharma Completes Treatment of Last Patient in midastouch017 02/21/17 08:30:41 AM
#589   Indeed sir. I'm sure you are already long. toddski 02/18/17 09:18:03 PM
#588   Sure looks solid to me and undervalued. We chef911 02/16/17 01:46:21 PM
#587   RedHill Biopharma to Host Fourth Quarter and Full-Year noretreat 02/16/17 09:35:28 AM
#586   Right, you simply won't find something similar on toddski 02/15/17 06:28:43 PM
#585   Thanks! Just listened to it. I tykundegex 02/15/17 06:14:11 PM
#584   Yeah it's on the events section of their toddski 02/15/17 02:44:46 PM
#583   I didn't know of any call scheduled for tykundegex 02/15/17 01:58:22 PM
#582   I listened to the conference call today. They toddski 02/14/17 09:44:15 PM
#581   Ok - RDHL is much more professional Amatuer17 02/14/17 10:02:25 AM
#580   Hey...I like this stock and it is one noretreat 02/14/17 09:45:47 AM
#579   CTIX would have a much better long-term outlook noretreat 02/14/17 09:43:41 AM
#578   Nice post. Eom scottsmith 02/14/17 06:12:43 AM
#577   NR - I hv read your posts so Amatuer17 02/14/17 05:38:35 AM
#576   Couple of things. First, all three phase three toddski 02/13/17 10:51:14 PM
#575   I'm sure they are legit. But as scottsmith 02/13/17 10:13:56 PM
#574   I've met with the management of Redhill a noretreat 02/13/17 10:03:53 PM
#573   Yep CTIX. Seems sometimes people don't trust scottsmith 02/13/17 09:47:34 PM
#572   Not sure what the Israeli factor is. The noretreat 02/13/17 09:39:02 PM
#571   Does all the cash on the balance sheet scottsmith 02/13/17 08:50:50 PM
#570   $120 million with lots of cash on the noretreat 02/13/17 05:33:58 PM
#569   Expected, but still good news. Company seems to noretreat 02/13/17 05:31:43 PM
#568   Funny how this company keeps being un-noticed and H2R 02/13/17 02:46:35 PM
#567   RedHill Biopharma Announces Enrollment of Last Patient in midastouch017 02/13/17 08:34:10 AM
#566   Bank Hapoalim BM Has $2,049,000 Position in Redhill midastouch017 02/06/17 03:05:27 PM
#564   no shit. biotechs tend to do that from TheHound 01/24/17 02:07:57 PM
#563   Not sure what is happening but this stock Amatuer17 01/24/17 01:26:33 PM
#562   A little low compared to others target price, drugmanrx 01/22/17 11:15:51 AM
#561   RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) target price midastouch017 01/22/17 10:17:25 AM
#560   Agree The next good milestone will be "RHB-104 - Crohn`s Amatuer17 01/12/17 12:12:44 PM
#559   Company is poised for a breakout year. Lots noretreat 01/12/17 10:11:00 AM
#558   RedHill Biopharma Provides 2017 Semi-Annual Business Update midastouch017 01/12/17 09:08:01 AM
#557   RDHL reminds me of my 7+ bagger LGND Amatuer17 01/11/17 08:42:17 AM
#556   RedHill Biopharma Announces QIDP Fast-Track Designation Granted by midastouch017 01/11/17 08:18:33 AM
#555   Another great news out today BioSpecialist 01/11/17 08:14:56 AM
#554   330 this afternoon noretreat 01/10/17 03:00:50 PM
#552   Nice presentation at the showcase today. No surprises, noretreat 01/10/17 01:53:47 PM
#551   Agreed. Well run company with a robust tykundegex 01/10/17 10:53:41 AM
#550   I do not like the share price but Amatuer17 01/10/17 09:03:02 AM
#549   RedHill Biopharma Announces First Dosing in RHB-105 Supportive midastouch017 01/10/17 08:31:48 AM
PostSubject